申请人:Ahrendt Kateri A.
公开号:US20110003809A1
公开(公告)日:2011-01-06
Compounds of Formula I are useful for inhibition of Raf kinases. Methods of using compounds of Formula I and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
公式I的化合物对于抑制Raf激酶非常有用。本文公开了使用公式I的化合物、立体异构体和药学上可接受的盐,在哺乳动物细胞中进行体外、体内和原位诊断、预防或治疗这种疾病或相关病理状态的方法。